Australia is experience a groundbreaking therapy for excess weight: Retatrutide. This dual compound – acting on both GLP-1 and GIP receptors – has remarkable outcomes in global studies, pointing to substantial drops in weight. While regulatory clearance hasn't occurred with the Therapeutic Goods Administration (TGA), several Australians dealing